Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Aug;19(8):735-740.
doi: 10.1016/j.hpb.2017.04.014. Epub 2017 May 23.

Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases

Affiliations
Comparative Study

Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases

Stefan Buettner et al. HPB (Oxford). 2017 Aug.

Abstract

Background: The aim of this study was to compare patients with PHC with lymph node metastases (LN+) who underwent a resection with patients who did not undergo resection because of locally advanced disease at exploratory laparotomy.

Methods: Consecutive LN+ patients who underwent a resection for PHC in 12 centers were compared with patients who did not undergo resection because of locally advanced disease at exploratory laparotomy in 2 centers.

Results: In the resected cohort of 119 patients, the median overall survival (OS) was 19 months and the estimated 1-, 3- and 5-year OS was 69%, 27% and 13%, respectively. In the non-resected cohort of 113 patients, median OS was 12 months and the estimated 1-, 3- and 5-year OS was 49%, 7%, and 3%, respectively. OS was better in the resected LN+ cohort (p < 0.001). Positive resection margin (hazard ratio [HR]: 1.54; 95%CI: 0.97-2.45) and lymphovascular invasion (LVI) (HR: 1.71; 95%CI: 1.09-2.69) were independent poor prognostic factors in the resected cohort.

Conclusion: Patients with PHC who underwent a resection for LN+ disease had better OS than patients who did not undergo resection because of locally advanced disease at exploratory laparotomy. LN+ PHC does not preclude 5-year survival after resection.

PubMed Disclaimer

Conflict of interest statement

Funds/conflict of interest: none

Figures

Figure 1
Figure 1
Overall survival stratified for treatment group (p < 0.001)
Figure 2
Figure 2
Overall Survival of Resected R1 Patients versus Non-Resected Patients (p = 0.086)
Figure 3
Figure 3
Overall Survival of Resected Lymphovascular Invasion Patients versus Non-Resected Patients (p = 0.073)

References

    1. Hartog H, Ijzermans JN, van Gulik TM, Groot Koerkamp B. Resection of Perihilar Cholangiocarcinoma. Surg Clin North Am. 2016;96(2):247–67. - PubMed
    1. Groot Koerkamp B, Fong Y. Outcomes in biliary malignancy. J Surg Oncol. 2014;110(5):585–91. - PubMed
    1. Jarnagin W, Winston C. Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford) 2005;7(4):244–51. - PMC - PubMed
    1. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg. 1995;19(1):83–8. - PubMed
    1. Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215(3):343–55. - PubMed

Publication types

MeSH terms